ASLN Stock Outstanding Shares
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Market Insider ASLN
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
Institutional Ownership
About 3,913% of ASLN shares are held by financial institutions. VIVO CAPITAL, LLC is the top corporate investor, holding 568.18K shares valued at $1.07M. A 3.46% stake in ASLAN Pharmaceuticals Limited is owned by the company. owns - shares valued at -, which translates its holding of N/A of the stake in the company.
Frequently Asked Questions
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ASLN shares is 17, representing 3,913% of the company's common stock.
VIVO CAPITAL, LLC, in the last quarter, reduced its stake in ASLN by -80% restricting it's holding to 568.18 thousand shares of worth nearly $1.07M. N/A also lessened N/A of the ASLN shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned ASLN shares holding by N/A last quarter which brought its holding to - shares worth -.
As per its latest 13F filing, N/A increased its stake in ASLN by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of ASLN to its portfolio, raising its holding to - shares of worth -. N/A also increased its ASLN shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in ASLN is N/A , N/A at the company. Additionally, ASLN stock is highly held by N/A N/A and N/A N/A among others.
Company executives, directors, and other insiders own 8% percent of ASLAN Pharmaceuticals Limited's stock. Within the last six months, there have been 0 transaction(s) in which ASLN insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .
There have been 0 transaction(s) during the past 6-months in which ASLAN Pharmaceuticals Limited insiders have bought stock, totalling 0 shares
Around 0 ASLAN Pharmaceuticals Limited shares are held by insiders, which represents about 8% of ASLN stock.
ASLN N/A, N/A holds the largest portfolio of the company's shares. ASLN shares owned by N/A total nearly -.
VIVO CAPITAL, LLC is the largest institutional owner in ASLN which holds 568.18 thousand shares worth $1.07M or 3.46% of the total ASLN shares outstanding followed by N/A with ownership of - shares representing N/A of the ASLN ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ASLN is concerned, it is a stock which is optionable.
Number of ASLN shares short is 38.32K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 2.83M shares of ASLN are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ASLN has 410.33M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ASLN is 1.85.